Jefferson Lab has a long history of aiding efforts in research and development of a wide range of detector technologies to aid physicians in earlier and more accurate diagnosis and treatment of breast cancer in nuclear medicine. With these new methods, cancer cells “light up” in breast imaging devices, leaving it no place to hide. From developing a new modality to dramatically decrease the number of false positive screens, to a device that enables a 3D molecular breast imager to detects cancers with six times greater precision and half the radiation dose, to a handheld scanner that helps surgeons remove all the cancer in the operating suite, Jefferson Lab is aiding the fight for breast cancer in women and men.
